drugset / Trial / NCT00567112

Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)

NCT00567112

Phase 1 Completed 18 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelTreatment

Summary

A study to compare the pharmacokinetics (PK) of the dry filled capsule (DFC) \& oral compressed tablet (OCT) formulations of MK-0941-009 \& to assess the effect of food on the OCT formulation.

Timeline

Start
2007-11
Primary completion
2008-02
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-0941 Small molecule 10 mg Oral